EzHomeo and HomeoGPT: evaluate an offer, not a launch date
HomeoGPT (homeogpt.in), checked 28 September 2026. Its public FAQ still describes a limited beta and a planned Q1 2024 release; today's access cannot be inferred from that page.
Evaluating EzHomeo? Start a reviewable consultation in the app and check the current workflow and terms before using patient data.
Scope: EzHomeo publishes this material and is commercially interested in homeopathy software. The guide evaluates software workflow and safeguards; it does not establish that homeopathy is effective for any condition and is not medical advice.
Why a practitioner might investigate HomeoGPT
HomeoGPT says its system draws on Dr. Samit Ghosh’s case archive and names repertory and materia medica sources. It describes follow-up questions about why a remedy was suggested and a configurable priority among sources. These are attractive research questions for a demonstration, not independent evidence of clinical accuracy or source rights (source).
The same public FAQ says users can type or dictate symptoms, describes limited beta testing and monthly and annual subscriptions without prices, and still mentions a Q1 2024 general release (source). We did not create an account or verify whether the waitlist or beta is currently open. Ask for current access, a live demonstration, actual prices and the contracting operator.
EzHomeo has a published purchase path now
EzHomeo’s site lists 10 starter consultation credits without a card, ₹999/month and ₹28,499 lifetime (source). Its published workflow begins with practitioner-controlled consultation recording, followed by transcript review and editable rubric suggestions, not just a typed symptom description (source). This is a site-described workflow, not one independently walked for this comparison.
If source-priority controls or questions about proposed remedies matter, request a HomeoGPT demo. If a priced consultation-capture plan matters now, inspect EzHomeo’s current checkout and test its review controls. Neither product’s published claims establish better treatment outcomes.
Status is a dated observation, not a prediction
HomeoGPT’s public FAQ may lag the product. This page records what it said on 28 September 2026; it does not assert that the beta is still running or that a launch failed. Confirm availability directly before making a purchase decision. EzHomeo’s editorial team must recheck this time-sensitive status by 27 December 2026. EzHomeo’s paid limits also require a checkout check.
Compare an available trial with a current demo
Try EzHomeo’s 10 starter credits and ask HomeoGPT for its current access and live demonstration. Do not treat a dated FAQ as proof that a waitlist still works.
Sources and further reading
Vendor information checked . Follow the references beside each claim to its source below.